Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.52B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
ProShares UltraPro QQQ
TQQQ
|
+$555M |
| 4 |
Dell
DELL
|
+$542M |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.18B |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.29B |
| 3 |
Visa
V
|
+$1.12B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$918M |
| 5 |
Broadcom
AVGO
|
+$892M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.93% |
| 2 | Consumer Discretionary | 1.52% |
| 3 | Healthcare | 0.84% |
| 4 | Financials | 0.83% |
| 5 | Communication Services | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MSD
8801
Morgan Stanley Emerging Markets Debt Fund
MSD
$148M
| $136K | ﹤0.01% |
+17,127
| New | +$132K |
|
8802
Compass Therapeutics
CMPX
$387M
| $135K | ﹤0.01% |
73,487
-79,577
| -52% | -$99.2K |
|
|
BLUE
8803
DELISTED
bluebird bio
BLUE
| $135K | ﹤0.01% |
12,961
-41,938
| -76% | -$697K |
|
8804
Organogenesis Holdings
ORGO
$239M
| $134K | ﹤0.01% |
46,866
-47,671
| -50% | -$134K |
|
8805
Lexicon Pharmaceuticals
LXRX
$1.1B
| $134K | ﹤0.01% |
85,361
-44,495
| -34% | -$79.2K |
|
|
RAPT
8806
DELISTED
RAPT Therapeutics
RAPT
| $134K | ﹤0.01% |
8,314
-16,813
| -67% | -$340K |
|
8807
Fossil Group
FOSL
$318M
| $134K | ﹤0.01% |
114,132
-162,333
| -59% | -$190K |
|
|
CTEV
8808
Claritev Corp
CTEV
$556M
| $133K | ﹤0.01% |
17,473
-27,879
| -61% | -$327K |
|
8809
CALL
Globalstar
GSAT
$10.8B
| $133K | ﹤0.01% |
7,160
+5,540
| +342% | +$103K |
|
8810
CALL
LifeMD
LFMD
$172M
| $133K | ﹤0.01% |
25,400
+14,400
| +131% | +$83K |
|
8811
PUT
Clover Health Investments
CLOV
$2.51B
| $133K | ﹤0.01% |
47,100
+10,700
| +29% | +$24.5K |
|
8812
ProShares Trust UltraShort MSCI Japan
EWV
$5.06M
| $132K | ﹤0.01% |
3,486
+167
| +5% | +$6.86K |
|
|
EXK
8813
PUT
Endeavour Silver
EXK
$2.83B
| $132K | ﹤0.01% |
33,600
+17,700
| +111% | +$65.1K |
|
|
FAZ
8814
CALL
Direxion Daily Financial Bear 3x ETF
FAZ
$86.7M
| $131K | ﹤0.01% |
+1,660
| New | +$149K |
|
8815
NN Inc
NNBR
$311M
| $131K | ﹤0.01% |
33,621
+12,362
| +58% | +$44.6K |
|
8816
FVCBankcorp
FVCB
$333M
| $131K | ﹤0.01% |
10,010
-7,297
| -42% | -$85.7K |
|
8817
CALL
Teucrium Wheat Fund
WEAT
$292M
| $130K | ﹤0.01% |
+4,980
| New | +$127K |
|
|
UNIT
8818
PUT
Uniti Group
UNIT
$2.32B
| $130K | ﹤0.01% |
23,100
-5,400
| -19% | -$23.1K |
|
8819
SoundHound AI Warrant
SOUNW
$787M
| $130K | ﹤0.01% |
69,981
| – | – |
|
|
FTF
8820
Franklin Limited Duration Income Trust
FTF
$233M
| $130K | ﹤0.01% |
+19,501
| New | +$129K |
|
8821
CALL
CryoPort
CYRX
$762M
| $130K | ﹤0.01% |
16,000
+3,800
| +31% | +$31.1K |
|
|
EDD
8822
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$385M
| $130K | ﹤0.01% |
+25,739
| New | +$126K |
|
8823
Talkspace
TALK
$874M
| $130K | ﹤0.01% |
62,000
-9,771
| -14% | -$19.1K |
|
8824
CALL
Mirion Technologies
MIR
$3.91B
| $130K | ﹤0.01% |
+11,700
| New | +$123K |
|
8825
Design Therapeutics
DSGN
$876M
| $129K | ﹤0.01% |
24,003
-33,902
| -59% | -$159K |
|
Similar funds
Jane Street's Q3 2024 Portfolio in Review
As of Q3 2024, Jane Street held 10,828 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Jane Street withdrew a net $18.5B in Q3 2024, closing 1,349 positions and reducing 4,327 holdings. Its most notable exit was iShares Core MSCI International Developed Markets ETF, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, down from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jane Street opened a new position in Schwab Short-Term US Treasury ETF worth $424M.
- Jane Street's largest Q3 2024 buy was Schwab Short-Term US Treasury ETF: 17,304,274 shares worth $424M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.52B increase.
- Jane Street's biggest Q3 2024 reduction was Apple, cutting an estimated $4.18B.
- Jane Street fully exited iShares Core MSCI International Developed Markets ETF in Q3 2024, selling an estimated $290M.
- Jane Street's ten largest holdings make up 44% of its $453B portfolio in Q3 2024.
- Jane Street opened 1,593 new positions and closed 1,349 in Q3 2024.
- Jane Street's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.